Chiara Signori graduated in Pharmaceutical Biotechnology at the University of Milan in 2021. For her thesis she worked at Mario Negri Research Institute, in the department of Clinical Cardiovascular Research. She then moved to Basel, Switzerland, where she worked at Roche on analytical methods for gene therapy products. In November 2022, she started her PhD at Humanitas University, working in the Carlo-Stella lab on a translational research project about lymphoma.